Previous close | 0.8000 |
Open | 0.8000 |
Bid | 0.0000 |
Ask | 1.5500 |
Strike | 90.00 |
Expiry date | 2024-05-17 |
Day's range | 0.8000 - 0.8000 |
Contract range | N/A |
Volume | |
Open interest | 80 |
Discover how Legend Biotech's robust Q1 performance and strategic initiatives are setting the stage for sustained growth.
Q1 2024 Legend Biotech Corp Earnings Call
SOMERSET, N.J., May 13, 2024--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today reported its first quarter 2024 unaudited financial results and key corporate highlights.